Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-05-15
1999-03-23
Huang, Evelyn
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
546105, A61K 31435, C07D21910
Patent
active
058860070
ABSTRACT:
The present invention provides cholinesterase inhibitors of general formula (I): ##STR1## wherein R is H or (C.sub.1 -C.sub.4)alkyl, Y is a linking group and Z is an aryl group, and the pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4631286 (1986-12-01), Shutske et al.
patent: 4816456 (1989-03-01), Summers
patent: 4868177 (1989-09-01), Shutske
patent: 5026897 (1991-06-01), Chiang et al.
patent: 5104880 (1992-04-01), Kozikowski
patent: 5391553 (1995-02-01), Shutske
Bindra, J.S., et al., "Synthesis, Pharmacological Activities & Physico-chemical Properties of 4-(Substituted amino/N4-arylpiperazinyl/aminocarbonyl)-2,3-polymethylenequinolines", Indian Journal of Chemistry, vol. 26B, pp. 318-329 (Apr. 1987).
Chen, T.K., et al., "Diacridines, Bifunctional INtercalators. Chemistry and Antitumor Activity", J. Med. Chem., 21, 868-874 (1978).
Davis, K.L., et al., "Tacrine", The Lancet, 345, 625-630 (1995).
Galanakis, D., et al., "Synthesis and Structure-Activity Relationships of Dequalinium Analogues as K+ Channel Blockers. Investigations on the Role of the Charged Heterocycle", J. Med. Chem., vol. 38, pp. 595-606 (1995).
Harel, M., et al., "Conversion of Acetylcholinesterase to Butyrylcholinesterase: Modeling and Mutagenesis", Proc. Natl. Acad. Sci. USA, 89, pp. 10827-10831 (Nov. 1992).
Himel, C.M., et al., "Acidine Araphanes: A New Class of Probe Molecules for Biological Systems", Science, 205, pp. 1277-1279 (1979).
Khachaturian, Z.S., "Diagnosis of Alzheimer's Disease", Arch. Neurol., 42, 1097-1105 (1985).
Nelson, M.E., et al., "9-Aminoacridines Act at a Site Different from that for Mg2+ in Blockade of the N-Methyl-D-Aspartate Receptor Channel", Mol. Pharmacol., 46, pp. 151-160 (1994).
Pang, Y., et al., "Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase", The Journal of Biological Chemistry, vol. 271, No. 39, pp. 23646-22649 (Sep. 27, 1996).
Patocka, J., et al., "Kinetics of Inhibiton of Cholinesterases by 1,2,3,4-Tetra-Hydro-9-Aminoacridine in vitro", Collect. Czech. Chem. Commun., 41, pp. 816-824 (1976).
Rastogi, S.N., et al., "Local Anaesthetic Activity of 9-Alkylamino-1,2,3,4-Tetrahydroacridines: Structure-Activity Relationship Study", Indian Journal of Pharmacology, 19, pp. 44-48 (1987).
Selkoe, D.J., "The Molecular Pathology of Alzheimer's Disease", Neuron, 6, pp. 487-498 (1991).
Steinberg, G.M., et al., "A Hydrophobic Binding Site in Acetylcholinesterase", Journal of Medicinal Chemistry, vol. 18, No. 11, pp. 1056-1061 (May 12, 1975).
Tanzi, R., et al., "Genetic Heterogeneity of Gene Defects Responsible for Familial Alzheimer's Disease", Genetica, 91, pp. 255-263 (1993).
Taylor, J.L., et al., "Conformers of Acetylcholinesterase: A Mechanism of Allosteric Control" Mol. Pharmacol., 45, pp. 74-83 (1994).
Wilson, I.B., et al., "A Power Reactivator of Alkylphosphate-Inhibited Acetylcholinesterase", Biochim. Biophys. Acta, 18, pp. 168-170 (1955).
Brimijoin Stephen
Pang Yuan-Ping
Huang Evelyn
Mayo Foundation for Medical Education and Research
LandOfFree
THA analogs useful as cholinesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with THA analogs useful as cholinesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and THA analogs useful as cholinesterase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2125685